Qrons (QRON) Operating Cash Flow per Share : $-0.00 (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Qrons Operating Cash Flow per Share?

Qrons's operating cash flow per share for the three months ended in Dec. 2024 was $0.00. Qrons's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 23.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 35.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Qrons's Operating Cash Flow per Share or its related term are showing as below:

QRON' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -67.1 Med: 28.6 Max: 42.5
Current: 23.7

During the past 9 years, Qrons's highest 3-Year average Operating Cash Flow per Share Growth Rate was 42.50% per year. The lowest was -67.10% per year. And the median was 28.60% per year.

QRON's 3-Year OCF Growth Rate is ranked better than
65.95% of 1213 companies
in the Biotechnology industry
Industry Median: 9.5 vs QRON: 23.70

Qrons Operating Cash Flow per Share Historical Data

The historical data trend for Qrons's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qrons Operating Cash Flow per Share Chart

Qrons Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.02

-0.01

Qrons Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Qrons's Operating Cash Flow per Share

For the Biotechnology subindustry, Qrons's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qrons's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qrons's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Qrons's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Qrons Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Qrons's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-0.062	/	13.894
	=	-0.00

Qrons's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-0.002	/	14.273
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

Qrons Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Qrons's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Qrons Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qrons Inc (OTCPK:QRON) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

611 N. Brand Boulevard, Suite 1300, Glendale, CA, USA, 91203

Website

https://www.firstpersongroup.com

Qrons Inc. is a biotechnology company, dedicated to developing biotech products, treatments, and technologies to combat neuronal and infectious diseases with a focus on antibiotic-resistant bacteria, which is becoming the prominent and rapidly growing world-wide cause of illness and death. The technology would treat a wide range of neurodegenerative diseases. The treatment integrates proprietary, engineered mesenchymal stem cells, 3D printable scaffolding, smart materials, and a novel delivery system. The company has two product candidates, QS100TM for treating penetrating brain injuries and QS200TM for treating concussions and other diffused axonal injuries.

Executives

John N Bonfiglio	officer: Chief Operating Officer	C/O MICROLIN BIO, INC., NEW YORK NY 10022
Jonah Meer	director, 10 percent owner, officer: CEO, CFO and Secretary	28-10 JACKSON AVENUE, #26N, LONG ISLAND CITY NY 11101
Ido Merfeld	director, 10 percent owner, officer: President	153 HAGILBOA STREET, NIRIT L3 44805